3% Hypertonic Saline Dosing for Severe Hyponatremia
For severe symptomatic hyponatremia, 3% hypertonic saline should be administered as boluses of 100-150 mL intravenously, with the goal of increasing serum sodium by 4-6 mEq/L within the first 1-2 hours to alleviate severe symptoms. 1
Dosing Considerations
Initial bolus approach:
Maximum correction limits:
Calculation Method
For continuous infusion when needed, the infusion rate can be estimated using:
- Body weight (kg) × desired rate of increase in sodium (mEq/L per hour) 3
- This formula provides the infusion rate in mL/kg per hour
Clinical Approach Based on Symptom Severity
Severely Symptomatic Hyponatremia
- Symptoms: Somnolence, obtundation, coma, seizures, or cardiorespiratory distress 4
- Approach: Emergency treatment with bolus hypertonic saline
- Goal: Increase serum sodium by 4-6 mEq/L within 1-2 hours 4
- Caution: Stop treatment once symptoms abate or after reaching the correction limit
Moderately Symptomatic Hyponatremia
- Symptoms: Nausea, vomiting, headache, confusion
- Approach: Less aggressive correction with 3% saline
- Goal: Increase serum sodium by 0.5-1 mEq/L per hour 5
Asymptomatic Hyponatremia
- Approach: Fluid restriction may be sufficient 5
- Goal: Gradual correction without hypertonic saline
Monitoring and Safety
- Frequent serum sodium measurements (every 2-4 hours initially)
- Be prepared to slow or stop treatment if correction exceeds 0.5 mEq/L per hour in chronic cases 5
- Have hypotonic fluids or desmopressin available to manage overcorrection 1
Special Considerations
- Patients with alcoholism, malnutrition, or liver disease are at higher risk for osmotic demyelination syndrome and require more cautious correction 2
- Re-administration should not occur until serum sodium is <155 mmol/L 2
- Rapid intermittent administration is preferred over continuous infusion for symptomatic hyponatremia 1
The treatment approach must balance the risks of untreated severe hyponatremia against the risks of overly rapid correction, with the primary goal of alleviating severe neurological symptoms while preventing osmotic demyelination syndrome.